Sun Pharma Q2 results: Speciality business key to getting US business on track

Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in
Q2FY20 against Rs 2397 crore in the corresponding quarter of the
previous year

Read more: https://www.businesstoday.in/current/cor...

Actual news in your location


Similar news

Mann ki Baat Highlights: India capable of becoming toy hub, says Modi 0 0 0
Ambani's Reliance buys stake in Future Group for Rs 24,713 cr 0 0 0
Ambani's Reliance buys stake in Future Group for Rs 24,713 cr 0 0 0
India's premium smartphone market grew 18% YoY in H1 2020; Samsung leads with 37% share 0 0 666
Reliance Retail to acquire Future Group's retail business for Rs 24,713 crore 0 0 666
PM Modi pitches for introducing farm education in schools 0 0 666
Vistara operates maiden long-haul flight from Delhi to London 0 0 666
US, UK gear up to produce coronavirus vaccine by 2020-end 0 0 666
Kishore Biyani's Future Enterprises postpones board meet to September 7 0 0 666
COVID-19: UK to permit emergency use of any effective coronavirus vaccine 0 0 666